Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Splenic Infarction in Patients with Philadelphia-negative Myeloproliferative Neoplasms.

Internal medicine (Tokyo, Japan) - 1 Dec 2022

Lee Myung-Won, Yeon Sang-Hoon, Ryu Hyewon, Song Ik-Chan, Lee Hyo-Jin, Yun Hwan-Jung, Kim Seon Young, Shin Kyung Sook, Jo Deog-Yeon

Abstract excerpt

Objective We retrospectively analyzed the prevalence and clinical features of splenic infarctions in patients with Philadelphia chromosome-negative myeloproliferative neoplasms (Ph- MPNs). Patients Patients diagnosed with essential thrombocythemia (ET), polycythemia vera (PV), prefibrotic/early primary myelofibrosis (pre-PMF), or PMF from January 1996 to October 2020 in Chungnam National University Hospital,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Mutation

Share to Myeloproliferative Disorders

Share to Polycythemia Vera

Share to Thrombocythemia, Essential

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 35527026
DOI: 10.2169/internalmedicine.9124-21
PMCID: PMC9790792

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Splenic Infarction in Patients with Philadelphia-negative Myeloproliferative Neoplasms.PMID 35527026Read ↗

Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.Semantic proximity Read ↗

Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension.Semantic proximity Read ↗

Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights.Semantic proximity Read ↗

Clinical insights into the origins of thrombosis in myeloproliferative neoplasms.Semantic proximity Read ↗

Current approaches to challenging scenarios in myeloproliferative neoplasms.Semantic proximity Read ↗

Splanchnic Vein Thrombosis in Myelofibrosis-An Underappreciated Hallmark of Disease Phenotype.Semantic proximity Read ↗

The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective.Semantic proximity Read ↗

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.Semantic proximity Read ↗

[Clinical and epidemiological characteristics of the Philadelphia negative myeloproliferative neoplasms in Chile].Semantic proximity Read ↗

[Clinical and epidemiological characteristics of the Philadelphia negative myeloproliferative neoplasms in Chile].Semantic proximity Read ↗

Incidence rates and risk factors for vascular events in patients with essential thrombocythemia: a multicenter study from Korea.Semantic proximity Read ↗

Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.